Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer

This publication has 85 references indexed in Scilit:

• Lumican is down-regulated in cells expressing endoglin. Evidence for an inverse correlationship between Endoglin and Lumican expression
  Matrix Biology, 2004
• Endoglin regulates nitric oxide‐dependent vasodilatation
  The FASEB Journal, 2004
• Hypoxic Induction of Endoglin via Mitogen-Activated Protein Kinases in Mouse Brain Microvascular Endothelial Cells
  Stroke, 2003
• Endoglin (CD105) Expression in Endometrial Carcinoma
  International Journal of Gynecological Pathology, 2003
• Endoglin expression as a measure of microvessel density in cervical cancer
  Obstetrics & Gynecology, 2000
• Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin
  European Journal Of Cancer, 2000
• Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts
  European Journal of Cell Biology, 1999
• Endoglin/CD 105 may not be an optimal tumor endothelial treatment target
  Breast Cancer Research and Treatment, 1996
• Role of angiogenesis in patients with cerebral ischemic stroke.
  Stroke, 1994
• Identification and expression of two forms of the human transforming growth factor‐β‐binding protein endoglin with distinct cytoplasmic regions
  European Journal of Immunology, 1993